Published in J Biol Chem on May 05, 1991
Peptide antimicrobial agents. Clin Microbiol Rev (2006) 6.04
A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc Natl Acad Sci U S A (1992) 2.92
Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans. J Virol (1993) 1.78
Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation. Proc Natl Acad Sci U S A (2008) 1.45
Biosynthesis of heparin. The D-glucuronosyl- and N-acetyl-D-glucosaminyltransferase reactions and their relation to polymer modification. Biochem J (1992) 0.96
Mucopolysaccharidosis type I, unique structure of accumulated heparan sulfate and increased N-sulfotransferase activity in mice lacking α-l-iduronidase. J Biol Chem (2011) 0.93
A single protein catalyzes both N-deacetylation and N-sulfation during the biosynthesis of heparan sulfate. Proc Natl Acad Sci U S A (1993) 0.89
Undersulfation of heparan sulfate restricts differentiation potential of mouse embryonic stem cells. J Biol Chem (2012) 0.88
Localization of human heparan glucosaminyl N-deacetylase/N-sulphotransferase to the trans-Golgi network. Biochem J (1997) 0.88
MicroRNA-24 suppression of N-deacetylase/N-sulfotransferase-1 (NDST1) reduces endothelial cell responsiveness to vascular endothelial growth factor A (VEGFA). J Biol Chem (2013) 0.81
Therapeutic approaches using host defence peptides to tackle herpes virus infections. Viruses (2009) 0.78
HARE-Mediated Endocytosis of Hyaluronan and Heparin Is Targeted by Different Subsets of Three Endocytic Motifs. Int J Cell Biol (2015) 0.77
NDST2 (N-Deacetylase/N-Sulfotransferase-2) Enzyme Regulates Heparan Sulfate Chain Length. J Biol Chem (2016) 0.75
Proteoglycans: structures and interactions. Annu Rev Biochem (1991) 6.53
Molecular diversity of heparan sulfate. J Clin Invest (2001) 5.40
Glycosaminoglycans and their binding to biological macromolecules. Annu Rev Biochem (1978) 4.51
Regulated diversity of heparan sulfate. J Biol Chem (1998) 3.93
Cell-surface glycosaminoglycans. Annu Rev Biochem (1984) 3.68
A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc Natl Acad Sci U S A (1992) 2.92
Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature (1999) 2.82
A rountine diagnostic test for IgA and IgM antibodies to rubella virus: absorption of IgG with Staphylococcus aureus. J Infect Dis (1974) 2.67
Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. Proc Natl Acad Sci U S A (1980) 2.61
Cell-surface heparan sulfate: an intercalated membrane proteoglycan. Proc Natl Acad Sci U S A (1981) 2.60
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J Biol Chem (1998) 2.47
Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin. FEBS Lett (1976) 2.34
Heparan sulfate: a piece of information. FASEB J (1996) 2.33
Biosynthesis of heparin. II. Formation of sulfamino groups. J Biol Chem (1973) 2.27
Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J Biol Chem (1993) 2.23
Structure of the pericellular matrix: association of heparan and chondroitin sulfates with fibronectin-procollagen fibers. Cell (1982) 2.20
A proteoglycan form of heparin and its degradation to single-chain molecules. J Biol Chem (1978) 2.18
Cell-surface heparan sulfate. Isolation and characterization of a proteoglycan from rat liver membranes. J Biol Chem (1979) 2.15
Structure of the antithrombin-binding site in heparin. Proc Natl Acad Sci U S A (1979) 2.08
Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J Biol Chem (1993) 2.07
Cell-surface heparan sulfate. Mechanisms of proteoglycan-cell association. J Biol Chem (1980) 2.04
The molecular-weight-dependence of the anti-coagulant activity of heparin. Biochem J (1978) 2.03
Defining the interleukin-8-binding domain of heparan sulfate. J Biol Chem (1998) 1.93
Structure and biological interactions of heparin and heparan sulfate. Adv Carbohydr Chem Biochem (2001) 1.89
Heparin-lipoprotein lipase interactions. Fed Proc (1977) 1.87
Domain structure of heparan sulfates from bovine organs. J Biol Chem (1996) 1.84
Further characterization of the antithrombin-binding sequence in heparin. Carbohydr Res (1982) 1.83
Relationship of heparan sulfate proteoglycans to the cytoskeleton and extracellular matrix of cultured fibroblasts. J Cell Biol (1984) 1.82
Mechanism of the anticoagulant action of heparin. Mol Cell Biochem (1982) 1.80
Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol (1994) 1.73
Dane particles, DNA polymerase, and e-antigen in two different categories of hepatitis B antigen carriers. Intervirology (1975) 1.70
Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. J Biol Chem (2001) 1.68
Distribution of sulphate and iduronic acid residues in heparin and heparan sulphate. Biochem J (1974) 1.59
More to "heparin" than anticoagulation. Thromb Res (1994) 1.57
Glycosaminoglycans and the regulation of blood coagulation. Biochem J (1993) 1.57
Extension and structural variability of the antithrombin-binding sequence in heparin. J Biol Chem (1984) 1.56
Heparan sulfate: lessons from knockout mice. J Clin Invest (2001) 1.56
The chondroitin 4-sulfate-protein linkage. J Biol Chem (1966) 1.55
Attempted isolation of a heparin proteoglycan from bovine liver capsule. Biochem J (1970) 1.53
Biosynthesis of heparin. Assay and properties of the microsomal uronosyl C-5 epimerase. J Biol Chem (1979) 1.53
Substrate adhesion of rat hepatocytes: a comparison of laminin and fibronectin as attachment proteins. J Cell Biol (1981) 1.52
Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer (2003) 1.52
Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4. Biochem J (1984) 1.49
Binding of herpes simplex virus to cellular heparan sulphate, an initial step in the adsorption process. J Gen Virol (1991) 1.49
Substrate specificity of heparanases from human hepatoma and platelets. J Biol Chem (1998) 1.47
Biosynthesis of heparin. Substrate specificity of heparosan N-sulfate D-glucuronosyl 5-epimerase. J Biol Chem (1984) 1.46
Identification of N-sulphated disaccharide units in heparin-like polysaccharides. Biochem J (1979) 1.44
Further characterization of the heparin-protein linkage region. Biochim Biophys Acta (1966) 1.44
Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate. J Biol Chem (1999) 1.42
The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis. EMBO Rep (2000) 1.41
Risk factors for diabetes insipidus in langerhans cell histiocytosis. Pediatr Blood Cancer (2006) 1.41
Biosynthesis of heparin. Concerted action of late polymer-modification reactions. J Biol Chem (1980) 1.38
Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J (1999) 1.38
Structure and affinity for antithrombin of heparan sulfate chains derived from basement membrane proteoglycans. J Biol Chem (1987) 1.38
Pathophysiology of heparan sulphate: many diseases, few drugs. J Intern Med (2013) 1.38
Possible improvement in uteroplacental blood flow during atrial natriuretic peptide infusion in preeclampsia. Obstet Gynecol (1994) 1.38
N-[3H]Acetyl-labeling, a convenient method for radiolabeling of glycosaminoglycans. Anal Biochem (1982) 1.37
Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C. J Biol Chem (1997) 1.35
The viability of cells grown or centrifuged in a new density gradient medium, Percoll(TM). Exp Cell Res (1977) 1.34
Interaction of lipoprotein lipase with native and modified heparin-like polysaccharides. Biochem J (1980) 1.33
Cleavage of macromolecular heparin by an enzyme from mouse mastocytoma. J Biol Chem (1975) 1.32
Evidence for an ionic binding of lipoprotein lipase to heparin. Biochem Biophys Res Commun (1971) 1.32
Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis. J Biol Chem (2000) 1.31
Identification of iduronic acid as the major sulfated uronic acid of heparin. J Biol Chem (1971) 1.30
Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis. Proc Natl Acad Sci U S A (2001) 1.26
Anticoagulant activity of heparin: isolation of antithrombin-binding sites. FEBS Lett (1976) 1.26
Binding of human extracellular superoxide dismutase C to sulphated glycosaminoglycans. Biochem J (1988) 1.26
Analysis of the migration behaviour of single microtubules in electric fields. Biochem Biophys Res Commun (2002) 1.26
Cystatin C, a human proteinase inhibitor, blocks replication of herpes simplex virus. J Virol (1990) 1.25
Biosynthesis of L-iduronic acid in heparin: epimerization of D-glucuronic acid on the polymer level. Biochem Biophys Res Commun (1972) 1.25
The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group. J Biol Chem (1983) 1.24
MRI-guided noninvasive ultrasound surgery. Med Phys (1993) 1.24
The effect of heparin on the inositol 1,4,5-trisphosphate receptor in rat liver microsomes. Dependence on sulphate content and chain length. FEBS Lett (1989) 1.23
Biosynthesis of heparin. Effects of n-butyrate on cultured mast cells. J Biol Chem (1985) 1.23
Biosynthesis of heparan sulfate. Coordination of polymer-modification reactions in a Chinese hamster ovary cell mutant defective in N-sulfotransferase. J Biol Chem (1991) 1.23
Substrate specificity of the heparan sulfate hexuronic acid 2-O-sulfotransferase. Biochemistry (2001) 1.22
Identification of the endothelial cell binding site for factor IX. Proc Natl Acad Sci U S A (1996) 1.21
The molecular size of the antithrombin-binding sequence in heparin. FEBS Lett (1980) 1.21
Biosynthesis of heparin. 3. Formation of iduronic acid residues. J Biol Chem (1974) 1.20
The structures of xylosylserine and galactosylxylosylserine from heparin. Biochim Biophys Acta (1966) 1.19
Biosynthesis of heparin. Studies on the microsomal sulfation process. J Biol Chem (1975) 1.19
Glycosaminoglycans in rat mucosal mast cells. Biochem J (1985) 1.19
Occurrence and biosynthesis of beta-glucuronidic linkages in heparin. J Biol Chem (1971) 1.18
Biosynthesis of heparin. Loss of C-5 hydrogen during conversion of D-glucuronic to L-iduronic acid residues. Biochem Biophys Res Commun (1976) 1.17
Location of actin, myosin, and microtubular structures during directed locomotion of Dictyostelium amebae. J Cell Biol (1984) 1.17
Biosynthesis of heparin/heparan sulfate. cDNA cloning and expression of D-glucuronyl C5-epimerase from bovine lung. J Biol Chem (1997) 1.16
Heparan sulfate proteoglycans are concentrated on the sinusoidal plasmalemmal domain and in intracellular organelles of hepatocytes. J Cell Biol (1985) 1.16
Interfragmentary compression forces of scaphoid screws in a sawbone cylinder model. Injury (2007) 1.16
Role of adenovirus antigens in the induction of virus neutralizing antibody. J Gen Virol (1968) 1.15
Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J Biol Chem (1995) 1.15
Degradation of heparin in mouse mastocytoma tissue. Biochem J (1971) 1.14
Age-dependent modulation of heparan sulfate structure and function. J Biol Chem (1998) 1.13
Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4. J Biol Chem (1986) 1.13
Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5. Carbohydr Res (1994) 1.13
Mode of degradation of the chondroitin sulphate proteoglycan in rat costal cartilage. Biochem J (1972) 1.13
Diurnal salivary cortisol patterns during pregnancy and after delivery: relationship to plasma corticotrophin-releasing-hormone. Clin Endocrinol (Oxf) (1990) 1.13